Clinical Trial Update: The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of erythropoietin alpha on vascular reactivity in incident peritoneal dialysis patients with chronic kidney disease and anem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• Complication of Peritoneal Dialysis

Drugs mentioned

• Erythropoietin alpha (erythropoietin alpha)

Snippet

Sponsor: National Kidney and Transplant Institute, Philippines | Conditions: Chronic Kidney Disease, Anemia | Phase 4 | Status: COMPLETED